Quick Takeaways
- Ikarian Capital, LLC filed SCHEDULE 13G/A for Spruce Biosciences Inc. Common Stock, par value $0.0001 per share (SPRB).
- Disclosed ownership: 11%.
- Date of event: 31 Oct 2025.
Ikarian Capital, LLC - 31 Oct 2025 SCHEDULE 13G/A Report for Spruce Biosciences Inc. Common Stock, par value $0.0001 per share (SPRB)
- Filing Manager
- Ikarian Capital, LLC
- Reporting Manager
- Ikarian Capital, LLC
- Symbol
- SPRB
- Shares outstanding
- 1,064,526 shares
- Disclosed Ownership
- 121,356 shares
- Ownership
- 11%
- Form type
- SCHEDULE 13G/A
- Filing time
- 07 Nov 2025, 16:30:02 UTC
- Date of event
- 31 Oct 2025
- Previous filing
- 08 Oct 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Ikarian Capital, LLC disclosed 11% ownership in Spruce Biosciences Inc. Common Stock, par value $0.0001 per share (SPRB) on 31 Oct 2025."
What Changed
- Previous schedule filing date: 08 Oct 2025.
- Current filing was accepted on 07 Nov 2025, 16:30.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Ikarian Capital, LLC | 11% | 121,356 | 0 | 121,356 | /s/ Neil Shahrestani | Neil Shahrestani, Sole Manager | |
| Neil Shahrestani | 11% | 121,356 | 0 | 121,356 | /s/ Neil Shahrestani | Neil Shahrestani |